List of works - Paul A VanderLaan

"Rounding" the Size of Pulmonary Nodules: Impact of Rounding Methods on Nodule Management, as Defined by the 2017 Fleischner Society Guidelines

scientific article

A 50-year-old man with cirrhosis and progressive hypoxemia.

scientific article published in September 2014

A case of hypercalcemia secondary to hot tub lung

scientific article published on December 2014

A microthymoma and no germinal centre in myasthenia gravis ⬇️

scientific article published on April 15, 2013

Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer

scientific article published on 05 July 2018

Acute hemorrhage from small bowel diverticula harboring strongyloidiasis and schistosomiasis

scientific article published on 01 May 2010

Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.

scientific article

Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer

scientific article published on 02 August 2018

Atypia of undetermined significance and nondiagnostic rates in The Bethesda System for Reporting Thyroid Cytopathology are inversely related

scientific article published on 01 March 2012

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.

scientific article

CCAAT/enhancer binding protein β is dispensable for development of lung adenocarcinoma.

scientific article

CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Ldlr-/- Mice

scientific article published on 03 July 2020

CT Manifestations of Tumor Spread Through Airspaces in Pulmonary Adenocarcinomas Presenting as Subsolid Nodules

scientific article published on 01 November 2018

CT Manifestations of Tumor Spread through Air Spaces in Lung Adenocarcinoma: Different Pathways toward Common Perspectives

scientific article published on 04 December 2018

Cases of ALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy.

scientific article

Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?

scientific article published in May 2011

Comparison of plasma-thrombin, HistoGel, and CellGel cell block preparation methods with paired ThinPrep slides in the setting of mediastinal granulomatous disease

scientific article published on 08 September 2018

Comprehensive Genomic Profiling Differentiates Metachronous Primary Small-Cell Lung Cancer From Late Recurrence.

scientific article

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.

scientific article published on 16 January 2017

Current and future trends in non-small cell lung cancer biomarker testing: The American experience

scientific article published on 01 September 2020

Cytologic rapid on-site evaluation of transthoracic computed tomography-guided lung needle biopsies: who should perform ROSE? A cross-institutional analysis of procedural and diagnostic outcomes

scientific article published on 14 January 2015

De novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancers

scientific article

De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma.

scientific article published on 24 August 2017

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.

scientific article

Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling

scientific article

Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma

scientific article published on 07 August 2019

EBUS-TBNA of pulmonary artery clot

scientific article published on 01 October 2014

EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.

scientific article

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): an overview and update for the cytopathologist

scientific article published on 23 April 2014

Esophagitis: a novel adverse event of crizotinib in a patient with ALK-positive non-small-cell lung cancer.

scientific article published in March 2013

Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice

scientific article

False positive diagnosis of lymph node metastases in a 34 year old woman with a history of extraskeletal myxoid chondroscarcoma: A root cause analysis

scientific article published on 05 November 2018

Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology

scientific article published on 20 March 2012

Fine-needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalities

scientific article published on 16 May 2016

Histopathological Demonstration of Subacute Endothelialization Following Aneurysm Retreatment with the Pipeline Embolization Device

scientific article published on 18 July 2018

Implementation of the Paris System for Reporting Urinary Cytology results in lower atypical diagnostic rates

scientific article published on 02 June 2017

Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice

scientific article published on 14 September 2019

Lung Adenocarcinoma Manifesting as Pure Ground-Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and Size

scientific article published on 30 May 2017

Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis

scientific article

Lymphangioleiomyomatosis

scientific article published on 01 June 2018

Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension

scientific article published on December 2016

Measurement Bias of Gross Pathologic Compared With Radiologic Tumor Size of Resected Lung Adenocarcinomas: Implications for the T-Stage Revisions in the Eighth Edition of the American Joint Committee on Cancer Staging Manual.

scientific article published on June 2017

Measuring and assuring quality performance in cytology: A toolkit

scientific article published on 01 June 2017

Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.

scientific article published on 14 March 2017

Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target

scientific article published on 04 May 2018

Molecular markers: Implications for cytopathology and specimen collection

scientific article

Morphologic characteristics of pulmonary adenocarcinomas manifesting as pure ground-glass nodules on CT.

scientific article published in December 2017

Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes.

scientific article published on 25 January 2017

Natural killer T cells in lipoprotein metabolism and atherosclerosis.

scientific article published on 22 September 2011

Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

scientific article published on 03 May 2019

Osseous and chondromatous metaplasia in calcific aortic valve stenosis

scientific article published on 29 August 2015

PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option?

scientific article published on 16 February 2018

Pathologic T Descriptor of Nonmucinous Lung Adenocarcinomas Now Based on Invasive Tumor Size: How Should Pathologists Measure Invasion?

scientific article published on 01 October 2018

Pill aspiration presenting as an endobronchial tumor

scientific article published in April 2014

Practical Approach to the Evaluation of Prosthetic Mechanical and Tissue Replacement Heart Valves

scientific article published on 03 May 2012

Pre-analytic error: A significant patient safety risk

scientific article published on 01 August 2018

Preoperative bronchial cytology for the assessment of tumor spread through air spaces in lung adenocarcinoma resection specimens

scientific article published on 03 February 2020

Preoperative cytologic interpretation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a 1-year multi-institutional experience

scientific article published on 21 December 2017

Pulmonary Sclerosing Pneumocytoma

scientific article published on 01 October 2018

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

scientific article

Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis

scientific article published on 21 February 2018

Rapidly fatal advanced EGFR-mutated lung cancers and the need for rapid tumor genotyping in clinical practice.

scientific article

Recovery of giant-cell myocarditis using combined cytolytic immunosuppression and mechanical circulatory support

scientific article published on 19 February 2014

Repeatedly nondiagnostic thyroid fine-needle aspirations do not modify malignancy risk

scientific article published on 09 December 2011

Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation.

scientific article

Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients with Non-Small-Cell Lung Cancer.

scientific article published on 6 April 2018

Size Measurement and T-staging of Lung Adenocarcinomas Manifesting as Solid Nodules ≤30 mm on CT: Radiology-Pathology Correlation

scientific article published on 27 February 2017

Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice.

scientific article published on 07 August 2013

Software-based risk stratification of pulmonary adenocarcinomas manifesting as pure ground glass nodules on computed tomography

scientific article published on 14 July 2017

Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer

scientific article published on 28 January 2014

The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review

scientific article published on 26 March 2015

The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT

scientific article published on 04 August 2020

The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathology.

scientific article published on 14 September 2011

The frequency of 'atypia of undetermined significance' interpretations for thyroid fine-needle aspirations is negatively correlated with histologically proven malignant outcomes

scientific article

The immune system and murine atherosclerosis.

scientific article published on December 2007

The rapidly evolving landscape of biomarker testing in non-small cell lung cancer

scientific article published on 05 August 2020

Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis.

scientific article

Tumor biomarker testing in non-small-cell lung cancer: A decade of change.

scientific article published on 4 January 2018

Updated Correlation of 22C3-PD-L1 ≥50% Expression with Driver Oncogene Mutations and Response to Pembrolizumab in the Kinase Inhibitor-Resistant Setting.

scientific article published in May 2018

Updates in Lung Cancer Cytopathology

scientific article published on 01 September 2018

Using the Model for Improvement and Plan-Do-Study-Act to effect SMART change and advance quality

scientific article published on 04 August 2020

Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology

scientific article

VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.

scientific article published on 28 October 2008

Yield of biliary stent cytology: Is it time to think lean?

scientific article published on 03 April 2019

List of works by Paul A VanderLaan

"Rounding" the Size of Pulmonary Nodules: Impact of Rounding Methods on Nodule Management, as Defined by the 2017 Fleischner Society Guidelines

A 50-year-old man with cirrhosis and progressive hypoxemia.

A case of hypercalcemia secondary to hot tub lung

A microthymoma and no germinal centre in myasthenia gravis ⬇️

Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer

Acute hemorrhage from small bowel diverticula harboring strongyloidiasis and schistosomiasis

Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.

Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer

Atypia of undetermined significance and nondiagnostic rates in The Bethesda System for Reporting Thyroid Cytopathology are inversely related

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.

CCAAT/enhancer binding protein β is dispensable for development of lung adenocarcinoma.

CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Ldlr-/- Mice

CT Manifestations of Tumor Spread Through Airspaces in Pulmonary Adenocarcinomas Presenting as Subsolid Nodules

CT Manifestations of Tumor Spread through Air Spaces in Lung Adenocarcinoma: Different Pathways toward Common Perspectives

Cases of ALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy.

Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?

Comparison of plasma-thrombin, HistoGel, and CellGel cell block preparation methods with paired ThinPrep slides in the setting of mediastinal granulomatous disease

Comprehensive Genomic Profiling Differentiates Metachronous Primary Small-Cell Lung Cancer From Late Recurrence.

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.

Current and future trends in non-small cell lung cancer biomarker testing: The American experience

Cytologic rapid on-site evaluation of transthoracic computed tomography-guided lung needle biopsies: who should perform ROSE? A cross-institutional analysis of procedural and diagnostic outcomes

De novo ALK kinase domain mutations are uncommon in kinase inhibitor-naïve ALK rearranged lung cancers

De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma.

De novo pulmonary small cell carcinomas and large cell neuroendocrine carcinomas harboring EGFR mutations: Lack of response to EGFR inhibitors.

Detection of Crizotinib-Sensitive Lung Adenocarcinomas With MET, ALK, and ROS1 Genomic Alterations via Comprehensive Genomic Profiling

Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma

EBUS-TBNA of pulmonary artery clot

EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): an overview and update for the cytopathologist

Esophagitis: a novel adverse event of crizotinib in a patient with ALK-positive non-small-cell lung cancer.

Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice

False positive diagnosis of lymph node metastases in a 34 year old woman with a history of extraskeletal myxoid chondroscarcoma: A root cause analysis

Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology

Fine-needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalities

Histopathological Demonstration of Subacute Endothelialization Following Aneurysm Retreatment with the Pipeline Embolization Device

Implementation of the Paris System for Reporting Urinary Cytology results in lower atypical diagnostic rates

Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice

Lung Adenocarcinoma Manifesting as Pure Ground-Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and Size

Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis

Lymphangioleiomyomatosis

Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension

Measurement Bias of Gross Pathologic Compared With Radiologic Tumor Size of Resected Lung Adenocarcinomas: Implications for the T-Stage Revisions in the Eighth Edition of the American Joint Committee on Cancer Staging Manual.

Measuring and assuring quality performance in cytology: A toolkit

Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.

Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target

Molecular markers: Implications for cytopathology and specimen collection

Morphologic characteristics of pulmonary adenocarcinomas manifesting as pure ground-glass nodules on CT.

Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes.

Natural killer T cells in lipoprotein metabolism and atherosclerosis.

Non-small cell lung cancer predictive biomarker testing via immunocytochemistry: Ways of future past?

Osseous and chondromatous metaplasia in calcific aortic valve stenosis

PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option?

Pathologic T Descriptor of Nonmucinous Lung Adenocarcinomas Now Based on Invasive Tumor Size: How Should Pathologists Measure Invasion?

Pill aspiration presenting as an endobronchial tumor

Practical Approach to the Evaluation of Prosthetic Mechanical and Tissue Replacement Heart Valves

Pre-analytic error: A significant patient safety risk

Preoperative bronchial cytology for the assessment of tumor spread through air spaces in lung adenocarcinoma resection specimens

Preoperative cytologic interpretation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a 1-year multi-institutional experience

Pulmonary Sclerosing Pneumocytoma

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis

Rapidly fatal advanced EGFR-mutated lung cancers and the need for rapid tumor genotyping in clinical practice.

Recovery of giant-cell myocarditis using combined cytolytic immunosuppression and mechanical circulatory support

Repeatedly nondiagnostic thyroid fine-needle aspirations do not modify malignancy risk

Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation.

Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients with Non-Small-Cell Lung Cancer.

Size Measurement and T-staging of Lung Adenocarcinomas Manifesting as Solid Nodules ≤30 mm on CT: Radiology-Pathology Correlation

Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice.

Software-based risk stratification of pulmonary adenocarcinomas manifesting as pure ground glass nodules on computed tomography

Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer

The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review

The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT

The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio: a proposed performance measure for reporting in The Bethesda System for thyroid cytopathology.

The frequency of 'atypia of undetermined significance' interpretations for thyroid fine-needle aspirations is negatively correlated with histologically proven malignant outcomes

The immune system and murine atherosclerosis.

The rapidly evolving landscape of biomarker testing in non-small cell lung cancer

Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis.

Tumor biomarker testing in non-small-cell lung cancer: A decade of change.

Updated Correlation of 22C3-PD-L1 ≥50% Expression with Driver Oncogene Mutations and Response to Pembrolizumab in the Kinase Inhibitor-Resistant Setting.